IRAK4 inhibitors (SignalChem Life Sciences)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameIRAK4 inhibitors (SignalChem Life Sciences)

Drug Alias NameIL-1 receptor-associated kinase 4 inhibitors (SignalChem Life Sciences)interleukin-1 receptor associated kinase 4 inhibitors (SignalChem Life Sciences)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitors

TargetsInterleukin-1 receptor-associated kinase 4

Therapy Area/IndicationsInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSignalchem Lifesciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSignalchem Lifesciences

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A